Clinical Trials Directory

Trials / Completed

CompletedNCT01103115

Calcium + Vitamin D Supplementation for Low Bone Mass in Adolescent Idiopathic Scoliosis (AIS)

Can Calcium and Vitamin D Supplementation Improve Bone Mineral Density and Curve Progression in Girls With Adolescent Idiopathic Scoliosis?

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
330 (actual)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
Female
Age
11 Years – 14 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether Calcium and Vit D supplementation is effective for improving low bone mass in Girls with Adolescent Idiopathic Scoliosis (AIS).

Detailed description

Adolescent Idiopathic Scoliosis (AIS) is a prevalent condition mainly affecting females with disease onset at early puberty. It can lead to serious health problems and is associated with low bone mass which can persist with growth. Osteopenia is found to be an important prognostic factor for curve progression in AIS. Nutritional studies indicated AIS subjects had low dietary calcium intake. Evidences suggested that Vit D insufficiency could be present in AIS. Calcium and vitamin D supplementation can therefore be a viable treatment option for low bone mass in AIS subjects. The primary objective of this prospective randomized double-blinded placebo-controlled trial is to find out whether calcium and vitamin D supplementation can improve bone mineral density (BMD) in osteopenic AIS subjects. The secondary objective of this study is to evaluate whether the supplementation is effective in controlling curve progression in AIS.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCalcium 600mg plus Vit D 400 IUDaily supplementation with 600mg Calcium plus 400IU Vitamin D3
DIETARY_SUPPLEMENTCalcium 600mg plus Vit D 800 IUDaily supplementation with 600mg Calcium plus 800IU Vitamin D3
DIETARY_SUPPLEMENTPlaceboplacebo tablets

Timeline

Start date
2010-04-01
Primary completion
2014-09-01
Completion
2015-02-01
First posted
2010-04-14
Last updated
2015-02-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01103115. Inclusion in this directory is not an endorsement.